Columbia University Medical Center, Tissue Engineering and Regenerative Medicine Laboratory, New York, NY 10032, USA.
Lancet. 2010 Aug 7;376(9739):440-8. doi: 10.1016/S0140-6736(10)60668-X.
A common approach for tissue regeneration is cell delivery, for example by direct transplantation of stem or progenitor cells. An alternative, by recruitment of endogenous cells, needs experimental evidence. We tested the hypothesis that the articular surface of the synovial joint can regenerate with a biological cue spatially embedded in an anatomically correct bioscaffold.
In this proof of concept study, the surface morphology of a rabbit proximal humeral joint was captured with laser scanning and reconstructed by computer-aided design. We fabricated an anatomically correct bioscaffold using a composite of poly-epsilon-caprolactone and hydroxyapatite. The entire articular surface of unilateral proximal humeral condyles of skeletally mature rabbits was surgically excised and replaced with bioscaffolds spatially infused with transforming growth factor beta3 (TGFbeta3)-adsorbed or TGFbeta3-free collagen hydrogel. Locomotion and weightbearing were assessed 1-2, 3-4, and 5-8 weeks after surgery. At 4 months, regenerated cartilage samples were retrieved from in vivo and assessed for surface fissure, thickness, density, chondrocyte numbers, collagen type II and aggrecan, and mechanical properties.
Ten rabbits received TGFbeta3-infused bioscaffolds, ten received TGFbeta3-free bioscaffolds, and three rabbits underwent humeral-head excision without bioscaffold replacement. All animals in the TGFbeta3-delivery group fully resumed weightbearing and locomotion 3-4 weeks after surgery, more consistently than those in the TGFbeta3-free group. Defect-only rabbits limped at all times. 4 months after surgery, TGFbeta3-infused bioscaffolds were fully covered with hyaline cartilage in the articular surface. TGFbeta3-free bioscaffolds had only isolated cartilage formation, and no cartilage formation occurred in defect-only rabbits. TGFbeta3 delivery yielded uniformly distributed chondrocytes in a matrix with collagen type II and aggrecan and had significantly greater thickness (p=0.044) and density (p<0.0001) than did cartilage formed without TGFbeta3. Compressive and shear properties of TGFbeta3-mediated articular cartilage did not differ from those of native articular cartilage, and were significantly greater than those of cartilage formed without TGFbeta3. Regenerated cartilage was avascular and integrated with regenerated subchondral bone that had well defined blood vessels. TGFbeta3 delivery recruited roughly 130% more cells in the regenerated articular cartilage than did spontaneous cell migration without TGFbeta3.
Our findings suggest that the entire articular surface of the synovial joint can regenerate without cell transplantation. Regeneration of complex tissues is probable by homing of endogenous cells, as exemplified by stratified avascular cartilage and vascularised bone. Whether cell homing acts as an adjunctive or alternative approach of cell delivery for regeneration of tissues with different organisational complexity warrants further investigation.
New York State Stem Cell Science; US National Institutes of Health.
组织再生的常用方法是细胞输送,例如通过直接移植干细胞或祖细胞。另一种方法是招募内源性细胞,需要实验证据。我们测试了这样一个假设,即在生物支架中空间嵌入生物信号,可以使滑膜关节的关节表面再生。
在本概念验证研究中,使用激光扫描捕获兔子近端肱骨关节的表面形态,并通过计算机辅助设计进行重建。我们使用聚己内酯和羟基磷灰石的复合材料制造了一个解剖学正确的生物支架。通过手术切除单侧成熟兔近端肱骨髁的整个关节表面,并将其替换为空间注入转化生长因子β 3(TGFβ3)吸附或 TGFβ3 游离胶原蛋白水凝胶的生物支架。手术后 1-2、3-4 和 5-8 周评估运动和负重情况。手术后 4 个月,从体内取出再生软骨样本,评估表面裂隙、厚度、密度、软骨细胞数量、胶原 II 型和聚集蛋白聚糖以及力学性能。
10 只兔子接受了 TGFβ3 输注生物支架,10 只接受了 TGFβ3 无生物支架,3 只兔子在没有生物支架替换的情况下进行了肱骨头切除。所有接受 TGFβ3 输送组的动物在手术后 3-4 周内完全恢复负重和运动,比 TGFβ3 无组更一致。仅缺陷兔一直跛行。手术后 4 个月,TGFβ3 输注生物支架完全覆盖关节表面的透明软骨。TGFβ3 无生物支架仅形成孤立的软骨,而仅缺陷兔则未形成软骨。TGFβ3 输送可使软骨细胞在富含胶原 II 型和聚集蛋白聚糖的基质中均匀分布,并具有显著更大的厚度(p=0.044)和密度(p<0.0001),而没有 TGFβ3 的软骨形成。TGFβ3 介导的关节软骨的压缩和剪切特性与天然关节软骨没有区别,并且明显大于没有 TGFβ3 的软骨形成。再生软骨无血管且与具有明确血管的再生软骨下骨整合。与没有 TGFβ3 的自发细胞迁移相比,TGFβ3 输送可招募约 130%的再生关节软骨中的细胞。
我们的发现表明,滑膜关节的整个关节表面可以在没有细胞移植的情况下再生。内源性细胞的归巢可能会再生复杂组织,例如分层无血管软骨和血管化骨。细胞归巢是否作为细胞输送的辅助或替代方法,用于组织再生的不同组织复杂性,值得进一步研究。
纽约州干细胞科学;美国国立卫生研究院。